Systemic administration of B-PMO targeting this repeat element causes the blocking of Mbnl1 sequestration, resulting in normal nuclear distribution and subsequent correction of abnormal RNA splicing, including for the chloride channel 1 gene, which is a primary contributor to myotonia [131]. This evidence concerns the gene MBNL1 and Myotonia.